{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:23:25Z","timestamp":1792794205041,"version":"4.5.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274343"],"award-info":[{"award-number":["82274343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405302"],"award-info":[{"award-number":["82405302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2024QH032"],"award-info":[{"award-number":["ZR2024QH032"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014761","name":"Qingdao Natural Science Foundation","doi-asserted-by":"crossref","award":["24-4-4-zrjj-111-jch"],"award-info":[{"award-number":["24-4-4-zrjj-111-jch"]}],"id":[{"id":"10.13039\/501100014761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02299-5","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T18:34:02Z","timestamp":1750185242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Common mechanisms of Gut microbe-based strategies for the treatment of intestine-related diseases: based on multi-target interactions with the intestinal barrier"],"prefix":"10.1186","volume":"23","author":[{"given":"Keyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"2299_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101537","volume":"73","author":"P Kemoun","year":"2022","unstructured":"Kemoun P, et al. A gerophysiology perspective on healthy ageing. Ageing Res Rev. 2022;73: 101537.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"2299_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049334","volume":"11","author":"M Bar\u00e9","year":"2021","unstructured":"Bar\u00e9 M, et al. Multimorbidity patterns of chronic conditions and geriatric syndromes in older patients from the MoPIM multicentre cohort study. BMJ Open. 2021;11(11): e049334.","journal-title":"BMJ Open"},{"key":"2299_CR3","doi-asserted-by":"crossref","unstructured":"Drzewoski J, Hanefeld M. The Current and Potential Therapeutic Use of Metformin-The Good Old Drug. Pharmaceuticals (Basel). 2021;14(2):122.","DOI":"10.3390\/ph14020122"},{"issue":"4","key":"2299_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.tem.2022.01.002","volume":"33","author":"J Martel","year":"2022","unstructured":"Martel J, et al. Gut barrier disruption and chronic disease. Trends Endocrinol Metab. 2022;33(4):247\u201365.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2299_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S2468-1253(24)00390-X","volume":"10","author":"MF Neurath","year":"2025","unstructured":"Neurath MF, Artis D, Becker C. The intestinal barrier: a pivotal role in health, inflammation, and cancer. Lancet Gastroenterol Hepatol. 2025;10(6):573\u201392.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"2299_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jcmgh.2016.12.006","volume":"3","author":"M Schumann","year":"2017","unstructured":"Schumann M, et al. Celiac Disease: Role of the Epithelial Barrier. Cell Mol Gastroenterol Hepatol. 2017;3(2):150\u201362.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2299_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107483","volume":"210","author":"K Chen","year":"2024","unstructured":"Chen K, et al. Targeting gut microbiota as a therapeutic target in T2DM: A review of multi-target interactions of probiotics, prebiotics, postbiotics, and synbiotics with the intestinal barrier. Pharmacol Res. 2024;210: 107483.","journal-title":"Pharmacol Res"},{"issue":"3","key":"2299_CR8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.immuni.2019.05.021","volume":"51","author":"M Noval Rivas","year":"2019","unstructured":"Noval Rivas M, et al. Intestinal Permeability and IgA Provoke Immune Vasculitis Linked to Cardiovascular Inflammation. Immunity. 2019;51(3):508-521.e6.","journal-title":"Immunity"},{"issue":"1","key":"2299_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12865-016-0187-3","volume":"18","author":"L Lin","year":"2017","unstructured":"Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017;18(1):2.","journal-title":"BMC Immunol"},{"issue":"5","key":"2299_CR10","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.apsb.2022.12.009","volume":"13","author":"W Wei","year":"2023","unstructured":"Wei W, et al. Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects. Acta Pharm Sin B. 2023;13(5):2138\u201351.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2299_CR11","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, et al. Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study). Nat Commun. 2020;11(1):5015.","journal-title":"Nat Commun"},{"issue":"12","key":"2299_CR12","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.apsb.2020.06.014","volume":"10","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5. Acta Pharm Sin B. 2020;10(12):2299\u2013312.","journal-title":"Acta Pharm Sin B"},{"key":"2299_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jare.2021.11.017","volume":"40","author":"S Chen","year":"2022","unstructured":"Chen S, et al. Targeted delivery of Chinese herb pair-based berberine\/tannin acid self-assemblies for the treatment of ulcerative colitis. J Adv Res. 2022;40:263\u201376.","journal-title":"J Adv Res"},{"key":"2299_CR14","doi-asserted-by":"publisher","first-page":"1187718","DOI":"10.3389\/fnut.2023.1187718","volume":"10","author":"F Yang","year":"2023","unstructured":"Yang F, et al. Berberine influences multiple diseases by modifying gut microbiota. Front Nutr. 2023;10:1187718.","journal-title":"Front Nutr"},{"issue":"5","key":"2299_CR15","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","volume":"11","author":"S Ghosh","year":"2021","unstructured":"Ghosh S, et al. Regulation of Intestinal Barrier Function by Microbial Metabolites. Cell Mol Gastroenterol Hepatol. 2021;11(5):1463\u201382.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"2299_CR16","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, et al. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020\u201332.","journal-title":"Gut"},{"issue":"11","key":"2299_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","volume":"9","author":"JR Turner","year":"2009","unstructured":"Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799\u2013809.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2299_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri2710","volume":"10","author":"LV Hooper","year":"2010","unstructured":"Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010;10(3):159\u201369.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2299_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","volume":"19","author":"KA Krautkramer","year":"2021","unstructured":"Krautkramer KA, Fan J, B\u00e4ckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19(2):77\u201394.","journal-title":"Nat Rev Microbiol"},{"key":"2299_CR20","doi-asserted-by":"crossref","unstructured":"He J, et al. Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. Int J Mol Sci. 2020;21(17):6356.","DOI":"10.3390\/ijms21176356"},{"issue":"3","key":"2299_CR21","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/mi.2017.118","volume":"11","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, et al. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunol. 2018;11(3):752\u201362.","journal-title":"Mucosal Immunol"},{"issue":"17","key":"2299_CR22","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.119.043081","volume":"141","author":"DM Kaye","year":"2020","unstructured":"Kaye DM, et al. Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease. Circulation. 2020;141(17):1393\u2013403.","journal-title":"Circulation"},{"issue":"4","key":"2299_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2020.03.003","volume":"31","author":"EC Rosser","year":"2020","unstructured":"Rosser EC, et al. Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells. Cell Metab. 2020;31(4):837-851.e10.","journal-title":"Cell Metab"},{"issue":"8049","key":"2299_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41586-024-08379-9","volume":"638","author":"TH Won","year":"2025","unstructured":"Won TH, et al. Host metabolism balances microbial regulation of bile acid signalling. Nature. 2025;638(8049):216\u201324.","journal-title":"Nature"},{"issue":"7","key":"2299_CR25","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.cmet.2021.04.009","volume":"33","author":"A Castellanos-Jankiewicz","year":"2021","unstructured":"Castellanos-Jankiewicz A, et al. Hypothalamic bile acid-TGR5 signaling protects from obesity. Cell Metab. 2021;33(7):1483-1492.e10.","journal-title":"Cell Metab"},{"issue":"12","key":"2299_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","volume":"15","author":"TR Ahmad","year":"2019","unstructured":"Ahmad TR, Haeusler RA. Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs. Nat Rev Endocrinol. 2019;15(12):701\u201312.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"2299_CR27","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","volume":"165","author":"A Koh","year":"2016","unstructured":"Koh A, et al. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016;165(6):1332\u201345.","journal-title":"Cell"},{"issue":"6","key":"2299_CR28","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/ismej.2014.14","volume":"8","author":"N Reichardt","year":"2014","unstructured":"Reichardt N, et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. Isme j. 2014;8(6):1323\u201335.","journal-title":"Isme j"},{"issue":"2","key":"2299_CR29","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1462-2920.2009.02066.x","volume":"12","author":"P Louis","year":"2010","unstructured":"Louis P, et al. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol. 2010;12(2):304\u201314.","journal-title":"Environ Microbiol"},{"issue":"5","key":"2299_CR30","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1084\/jem.2.5.543","volume":"2","author":"T Smith","year":"1897","unstructured":"Smith T. A MODIFICATION OF THE METHOD FOR DETERMINING THE PRODUCTION OF INDOL BY BACTERIA. J Exp Med. 1897;2(5):543\u20137.","journal-title":"J Exp Med"},{"issue":"4","key":"2299_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1574-6976.2009.00204.x","volume":"34","author":"JH Lee","year":"2010","unstructured":"Lee JH, Lee J. Indole as an intercellular signal in microbial communities. FEMS Microbiol Rev. 2010;34(4):426\u201344.","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"2299_CR32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.chom.2014.09.001","volume":"16","author":"BB Williams","year":"2014","unstructured":"Williams BB, et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe. 2014;16(4):495\u2013503.","journal-title":"Cell Host Microbe"},{"key":"2299_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mam.2017.06.002","volume":"56","author":"SL Long","year":"2017","unstructured":"Long SL, Gahan CGM, Joyce SA. Interactions between gut bacteria and bile in health and disease. Mol Aspects Med. 2017;56:54\u201365.","journal-title":"Mol Aspects Med"},{"key":"2299_CR34","doi-asserted-by":"crossref","unstructured":"Li W, Chen H, Tang J. Interplay between Bile Acids and Intestinal Microbiota: Regulatory Mechanisms and Therapeutic Potential for Infections. Pathogens. 2024;13(8):702.","DOI":"10.3390\/pathogens13080702"},{"issue":"2","key":"2299_CR35","doi-asserted-by":"publisher","first-page":"G81","DOI":"10.1152\/ajpgi.00065.2015","volume":"310","author":"AY Dossa","year":"2016","unstructured":"Dossa AY, et al. Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling. Am J Physiol Gastrointest Liver Physiol. 2016;310(2):G81-92.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"2299_CR36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","volume":"145","author":"MH Kim","year":"2013","unstructured":"Kim MH, et al. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterol. 2013;145(2):396\u2013406 e1\u201310.","journal-title":"Gastroenterol."},{"issue":"5","key":"2299_CR37","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/all.15069","volume":"77","author":"MTA Kleuskens","year":"2022","unstructured":"Kleuskens MTA, et al. Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function. Allergy. 2022;77(5):1510\u201321.","journal-title":"Allergy"},{"issue":"2","key":"2299_CR38","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","volume":"61","author":"G Tolhurst","year":"2012","unstructured":"Tolhurst G, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364\u201371.","journal-title":"Diabetes"},{"issue":"8","key":"2299_CR39","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.1007\/s11033-020-05611-3","volume":"47","author":"J Kumar","year":"2020","unstructured":"Kumar J, Rani K, Datt C. Molecular link between dietary fibre, gut microbiota and health. Mol Biol Rep. 2020;47(8):6229\u201337.","journal-title":"Mol Biol Rep"},{"key":"2299_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.119903","volume":"296","author":"N Zhang","year":"2022","unstructured":"Zhang N, et al. Neoagarotetraose alleviates high fat diet induced obesity via white adipocytes browning and regulation of gut microbiota. Carbohydr Polym. 2022;296: 119903.","journal-title":"Carbohydr Polym"},{"issue":"7","key":"2299_CR41","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/db14-1213","volume":"64","author":"G den Besten","year":"2015","unstructured":"den Besten G, et al. Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPAR\u03b3-Dependent Switch From Lipogenesis to Fat Oxidation. Diabetes. 2015;64(7):2398\u2013408.","journal-title":"Diabetes"},{"issue":"8","key":"2299_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024;24(8):577\u201395.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2299_CR43","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","volume":"50","author":"J Schulthess","year":"2019","unstructured":"Schulthess J, et al. The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages. Immunity. 2019;50(2):432-445.e7.","journal-title":"Immunity"},{"issue":"1","key":"2299_CR44","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","volume":"11","author":"W Yang","year":"2020","unstructured":"Yang W, et al. Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020;11(1):4457.","journal-title":"Nat Commun"},{"issue":"7","key":"2299_CR45","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","volume":"69","author":"M Thangaraju","year":"2009","unstructured":"Thangaraju M, et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 2009;69(7):2826\u201332.","journal-title":"Cancer Res"},{"key":"2299_CR46","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fimmu.2017.01036","volume":"8","author":"M Kespohl","year":"2017","unstructured":"Kespohl M, et al. The Microbial Metabolite Butyrate Induces Expression of Th1-Associated Factors in CD4(+) T Cells. Front Immunol. 2017;8:1036.","journal-title":"Front Immunol"},{"issue":"9","key":"2299_CR47","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/ibd\/izz046","volume":"25","author":"L Chen","year":"2019","unstructured":"Chen L, et al. Microbiota Metabolite Butyrate Differentially Regulates Th1 and Th17 Cells\u2019 Differentiation and Function in Induction of Colitis. Inflamm Bowel Dis. 2019;25(9):1450\u201361.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"2299_CR48","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.celrep.2014.10.032","volume":"9","author":"C Chimerel","year":"2014","unstructured":"Chimerel C, et al. Bacterial metabolite indole modulates incretin secretion from intestinal enteroendocrine L cells. Cell Rep. 2014;9(4):1202\u20138.","journal-title":"Cell Rep"},{"key":"2299_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108384","volume":"83","author":"WC Liu","year":"2020","unstructured":"Liu WC, Chen PH, Chen LW. Supplementation of endogenous Ahr ligands reverses insulin resistance and associated inflammation in an insulin-dependent diabetic mouse model. J Nutr Biochem. 2020;83: 108384.","journal-title":"J Nutr Biochem"},{"issue":"10","key":"2299_CR50","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.4049\/jimmunol.1700289","volume":"199","author":"J Li","year":"2017","unstructured":"Li J, et al. Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis. J Immunol. 2017;199(10):3504\u201315.","journal-title":"J Immunol"},{"issue":"7","key":"2299_CR51","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.celrep.2019.10.018","volume":"29","author":"CJM Piper","year":"2019","unstructured":"Piper CJM, et al. Aryl Hydrocarbon Receptor Contributes to the Transcriptional Program of IL-10-Producing Regulatory B Cells. Cell Rep. 2019;29(7):1878-1892.e7.","journal-title":"Cell Rep"},{"issue":"1","key":"2299_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13098-023-01207-6","volume":"15","author":"Y Hou","year":"2023","unstructured":"Hou Y, et al. Research progress on the relationship between bile acid metabolism and type 2 diabetes mellitus. Diabetol Metab Syndr. 2023;15(1):235.","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"2299_CR53","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/JOE-15-0469","volume":"228","author":"L V\u00edtek","year":"2016","unstructured":"V\u00edtek L, Haluz\u00edk M. The role of bile acids in metabolic regulation. J Endocrinol. 2016;228(3):R85-96.","journal-title":"J Endocrinol"},{"key":"2299_CR54","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3389\/fphar.2018.01382","volume":"9","author":"M \u00d0ani\u0107","year":"2018","unstructured":"\u00d0ani\u0107 M, et al. Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome. Front Pharmacol. 2018;9:1382.","journal-title":"Front Pharmacol"},{"issue":"7790","key":"2299_CR55","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","volume":"577","author":"X Song","year":"2020","unstructured":"Song X, et al. Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis. Nature. 2020;577(7790):410\u20135.","journal-title":"Nature"},{"issue":"7798","key":"2299_CR56","doi-asserted-by":"publisher","first-page":"E7","DOI":"10.1038\/s41586-020-2030-5","volume":"579","author":"S Hang","year":"2020","unstructured":"Hang S, et al. Author Correction: Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature. 2020;579(7798):E7.","journal-title":"Nature"},{"issue":"4","key":"2299_CR57","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.24525","volume":"54","author":"YD Wang","year":"2011","unstructured":"Wang YD, et al. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor \u03ba light-chain enhancer of activated B cells (NF-\u03baB) in mice. Hepatology. 2011;54(4):1421\u201332.","journal-title":"Hepatology"},{"issue":"6","key":"2299_CR58","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41385-018-0039-y","volume":"11","author":"KA Knoop","year":"2018","unstructured":"Knoop KA, Newberry RD. Goblet cells: multifaceted players in immunity at mucosal surfaces. Mucosal Immunol. 2018;11(6):1551\u20137.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"2299_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/asj.13357","volume":"91","author":"T Suzuki","year":"2020","unstructured":"Suzuki T. Regulation of the intestinal barrier by nutrients: The role of tight junctions. Anim Sci J. 2020;91(1): e13357.","journal-title":"Anim Sci J"},{"issue":"7585","key":"2299_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature16527","volume":"529","author":"F Gerbe","year":"2016","unstructured":"Gerbe F, et al. Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. Nature. 2016;529(7585):226\u201330.","journal-title":"Nature"},{"issue":"6","key":"2299_CR61","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.it.2011.04.003","volume":"32","author":"M Rescigno","year":"2011","unstructured":"Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol. 2011;32(6):256\u201364.","journal-title":"Trends Immunol"},{"issue":"12","key":"2299_CR62","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41575-022-00675-x","volume":"19","author":"JK Gustafsson","year":"2022","unstructured":"Gustafsson JK, Johansson MEV. The role of goblet cells and mucus in intestinal homeostasis. Nat Rev Gastroenterol Hepatol. 2022;19(12):785\u2013803.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"2299_CR63","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/femsre\/fuz013","volume":"43","author":"L Etienne-Mesmin","year":"2019","unstructured":"Etienne-Mesmin L, et al. Experimental models to study intestinal microbes-mucus interactions in health and disease. FEMS Microbiol Rev. 2019;43(5):457\u201389.","journal-title":"FEMS Microbiol Rev"},{"key":"2299_CR64","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1038\/ncomms9292","volume":"6","author":"H Li","year":"2015","unstructured":"Li H, et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat Commun. 2015;6:8292.","journal-title":"Nat Commun"},{"issue":"8","key":"2299_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1\u20139.","journal-title":"Exp Mol Med"},{"issue":"4","key":"2299_CR66","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/jn\/nxy008","volume":"148","author":"TV Hung","year":"2018","unstructured":"Hung TV, Suzuki T. Dietary Fermentable Fibers Attenuate Chronic Kidney Disease in Mice by Protecting the Intestinal Barrier. J Nutr. 2018;148(4):552\u201361.","journal-title":"J Nutr"},{"key":"2299_CR67","doi-asserted-by":"publisher","first-page":"3745135","DOI":"10.1155\/2022\/3745135","volume":"2022","author":"X Li","year":"2022","unstructured":"Li X, et al. Sodium Butyrate Ameliorates Oxidative Stress-Induced Intestinal Epithelium Barrier Injury and Mitochondrial Damage through AMPK-Mitophagy Pathway. Oxid Med Cell Longev. 2022;2022:3745135.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"2299_CR68","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2020.05.067","volume":"159","author":"G Sorrentino","year":"2020","unstructured":"Sorrentino G, et al. Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration. Gastroenterology. 2020;159(3):956-968.e8.","journal-title":"Gastroenterology"},{"issue":"4","key":"2299_CR69","first-page":"941","volume":"36","author":"HY Lee","year":"2010","unstructured":"Lee HY, et al. Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR\/PKC\/Ras\/ERK\/CREB, PI3K\/Akt\/IkappaB\/NF-kappaB and p38\/MSK1\/CREB pathways and negative JNK\/c-Jun\/AP-1 pathway. Int J Oncol. 2010;36(4):941\u201353.","journal-title":"Int J Oncol"},{"issue":"4","key":"2299_CR70","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","volume":"60","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta RM, et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut. 2011;60(4):463\u201372.","journal-title":"Gut"},{"issue":"1","key":"2299_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1882927","volume":"13","author":"F Hosseinkhani","year":"2021","unstructured":"Hosseinkhani F, et al. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases. Gut Microbes. 2021;13(1):1\u201322.","journal-title":"Gut Microbes"},{"issue":"10","key":"2299_CR72","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol. 2014;14(10):667\u201385.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2299_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13843","volume":"32","author":"MF Viola","year":"2020","unstructured":"Viola MF, Boeckxstaens G. Intestinal resident macrophages: Multitaskers of the gut. Neurogastroenterol Motil. 2020;32(8): e13843.","journal-title":"Neurogastroenterol Motil"},{"key":"2299_CR74","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.3389\/fimmu.2018.02733","volume":"9","author":"CC Bain","year":"2018","unstructured":"Bain CC, Schridde A. Origin, Differentiation, and Function of Intestinal Macrophages. Front Immunol. 2018;9:2733.","journal-title":"Front Immunol"},{"issue":"8","key":"2299_CR75","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ni.3205","volume":"16","author":"X Su","year":"2015","unstructured":"Su X, et al. Interferon-\u03b3 regulates cellular metabolism and mRNA translation to potentiate macrophage activation. Nat Immunol. 2015;16(8):838\u201349.","journal-title":"Nat Immunol"},{"issue":"6","key":"2299_CR76","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1073\/pnas.1322269111","volume":"111","author":"PV Chang","year":"2014","unstructured":"Chang PV, et al. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A. 2014;111(6):2247\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2299_CR77","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1053\/j.gastro.2020.07.004","volume":"159","author":"MR Spalinger","year":"2020","unstructured":"Spalinger MR, et al. PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function. Gastroenterology. 2020;159(5):1763-1777.e14.","journal-title":"Gastroenterology"},{"issue":"11","key":"2299_CR78","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/j.cmet.2023.09.010","volume":"35","author":"SD Fritsch","year":"2023","unstructured":"Fritsch SD, et al. Metabolic support by macrophages sustains colonic epithelial homeostasis. Cell Metab. 2023;35(11):1931-1943.e8.","journal-title":"Cell Metab"},{"key":"2299_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122452","volume":"344","author":"X Hu","year":"2024","unstructured":"Hu X, et al. The intestinal epithelial-macrophage-crypt stem cell axis plays a crucial role in regulating and maintaining intestinal homeostasis. Life Sci. 2024;344: 122452.","journal-title":"Life Sci"},{"issue":"12","key":"2299_CR80","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.immuni.2023.11.003","volume":"56","author":"L Brockmann","year":"2023","unstructured":"Brockmann L, et al. Intestinal microbiota-specific Th17 cells possess regulatory properties and suppress effector T cells via c-MAF and IL-10. Immunity. 2023;56(12):2719-2735.e7.","journal-title":"Immunity"},{"issue":"11","key":"2299_CR81","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105320","volume":"40","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, et al. Fungal-induced glycolysis in macrophages promotes colon cancer by enhancing innate lymphoid cell secretion of IL-22. Embo j. 2021;40(11): e105320.","journal-title":"Embo j"},{"issue":"3","key":"2299_CR82","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41590-020-0602-z","volume":"21","author":"KR James","year":"2020","unstructured":"James KR, et al. Distinct microbial and immune niches of the human colon. Nat Immunol. 2020;21(3):343\u201353.","journal-title":"Nat Immunol"},{"issue":"1","key":"2299_CR83","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-immunol-090222-100246","volume":"42","author":"A Lockhart","year":"2024","unstructured":"Lockhart A, Mucida D, Bilate AM. Intraepithelial Lymphocytes of the Intestine. Annu Rev Immunol. 2024;42(1):289\u2013316.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"2299_CR84","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41577-023-00890-w","volume":"23","author":"D Ramanan","year":"2023","unstructured":"Ramanan D, et al. Regulatory T cells in the face of the intestinal microbiota. Nat Rev Immunol. 2023;23(11):749\u201362.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2299_CR85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-022-01387-9","volume":"24","author":"A Schnell","year":"2023","unstructured":"Schnell A, Littman DR, Kuchroo VK. T(H)17 cell heterogeneity and its role in tissue inflammation. Nat Immunol. 2023;24(1):19\u201329.","journal-title":"Nat Immunol"},{"issue":"7933","key":"2299_CR86","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41586-022-05141-x","volume":"610","author":"M Lyu","year":"2022","unstructured":"Lyu M, et al. ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut. Nature. 2022;610(7933):744\u201351.","journal-title":"Nature"},{"issue":"3","key":"2299_CR87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/intimm\/dxs113","volume":"25","author":"O Pabst","year":"2013","unstructured":"Pabst O. Trafficking of regulatory T cells in the intestinal immune system. Int Immunol. 2013;25(3):139\u201343.","journal-title":"Int Immunol"},{"issue":"3","key":"2299_CR88","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/25785826.2019.1658516","volume":"42","author":"H Sumida","year":"2019","unstructured":"Sumida H. Dynamics and clinical significance of intestinal intraepithelial lymphocytes. Immunol Med. 2019;42(3):117\u201323.","journal-title":"Immunol Med"},{"issue":"7436","key":"2299_CR89","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature11813","volume":"494","author":"CS Klose","year":"2013","unstructured":"Klose CS, et al. A T-bet gradient controls the fate and function of CCR6-ROR\u03b3t+ innate lymphoid cells. Nature. 2013;494(7436):261\u20135.","journal-title":"Nature"},{"key":"2299_CR90","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fimmu.2012.00072","volume":"3","author":"K Hoorweg","year":"2012","unstructured":"Hoorweg K, et al. Functional Differences between Human NKp44(-) and NKp44(+) RORC(+) Innate Lymphoid Cells. Front Immunol. 2012;3:72.","journal-title":"Front Immunol"},{"issue":"6178","key":"2299_CR91","doi-asserted-by":"publisher","first-page":"1249288","DOI":"10.1126\/science.1249288","volume":"343","author":"A Mortha","year":"2014","unstructured":"Mortha A, et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science. 2014;343(6178):1249288.","journal-title":"Science"},{"issue":"6","key":"2299_CR92","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41575-024-00906-3","volume":"21","author":"V Horn","year":"2024","unstructured":"Horn V, Sonnenberg GF. Group 3 innate lymphoid cells in intestinal health and disease. Nat Rev Gastroenterol Hepatol. 2024;21(6):428\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"2299_CR93","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.it.2024.01.006","volume":"45","author":"M Bemark","year":"2024","unstructured":"Bemark M, et al. Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity. Trends Immunol. 2024;45(3):211\u201323.","journal-title":"Trends Immunol"},{"issue":"1","key":"2299_CR94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41385-019-0227-4","volume":"13","author":"O Pabst","year":"2020","unstructured":"Pabst O, Slack E. IgA and the intestinal microbiota: the importance of being specific. Mucosal Immunol. 2020;13(1):12\u201321.","journal-title":"Mucosal Immunol"},{"issue":"10","key":"2299_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/ctg.2016.54","volume":"7","author":"J K\u00f6nig","year":"2016","unstructured":"K\u00f6nig J, et al. Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol. 2016;7(10): e196.","journal-title":"Clin Transl Gastroenterol"},{"issue":"8","key":"2299_CR96","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41579-019-0213-6","volume":"17","author":"M Schirmer","year":"2019","unstructured":"Schirmer M, et al. Microbial genes and pathways in inflammatory bowel disease. Nat Rev Microbiol. 2019;17(8):497\u2013511.","journal-title":"Nat Rev Microbiol"},{"issue":"34","key":"2299_CR97","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","volume":"104","author":"DN Frank","year":"2007","unstructured":"Frank DN, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2299_CR98","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1128\/JCM.43.7.3380-3389.2005","volume":"43","author":"A Swidsinski","year":"2005","unstructured":"Swidsinski A, et al. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005;43(7):3380\u20139.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"2299_CR99","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1128\/JCM.01004-06","volume":"44","author":"U Gophna","year":"2006","unstructured":"Gophna U, et al. Differences between tissue-associated intestinal microfloras of patients with Crohn\u2019s disease and ulcerative colitis. J Clin Microbiol. 2006;44(11):4136\u201341.","journal-title":"J Clin Microbiol"},{"key":"2299_CR100","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1146\/annurev-med-042320-021020","volume":"73","author":"Y Shan","year":"2022","unstructured":"Shan Y, Lee M, Chang EB. The Gut Microbiome and Inflammatory Bowel Diseases. Annu Rev Med. 2022;73:455\u201368.","journal-title":"Annu Rev Med"},{"issue":"6015","key":"2299_CR101","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337\u201341.","journal-title":"Science"},{"key":"2299_CR102","doi-asserted-by":"crossref","unstructured":"Hu Y, et al. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease. Nutrients. 2022;14(23):5140.","DOI":"10.3390\/nu14235140"},{"key":"2299_CR103","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"},{"issue":"23","key":"2299_CR104","doi-asserted-by":"publisher","first-page":"6294","DOI":"10.1128\/MCB.00939-09","volume":"29","author":"AL Cattin","year":"2009","unstructured":"Cattin AL, et al. Hepatocyte nuclear factor 4alpha, a key factor for homeostasis, cell architecture, and barrier function of the adult intestinal epithelium. Mol Cell Biol. 2009;29(23):6294\u2013308.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"2299_CR105","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ibd.20413","volume":"14","author":"SH Ahn","year":"2008","unstructured":"Ahn SH, et al. Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(7):908\u201320.","journal-title":"Inflamm Bowel Dis"},{"issue":"23","key":"2299_CR106","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","volume":"65","author":"F van Roy","year":"2008","unstructured":"van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65(23):3756\u201388.","journal-title":"Cell Mol Life Sci"},{"key":"2299_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103751","volume":"74","author":"D Yao","year":"2021","unstructured":"Yao D, et al. MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis. EBioMedicine. 2021;74: 103751.","journal-title":"EBioMedicine"},{"issue":"43","key":"2299_CR108","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2205277119","volume":"119","author":"G Cantero-Recasens","year":"2022","unstructured":"Cantero-Recasens G, et al. The ulcerative colitis-associated gene FUT8 regulates the quantity and quality of secreted mucins. Proc Natl Acad Sci U S A. 2022;119(43): e2205277119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2299_CR109","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"YR Na","year":"2019","unstructured":"Na YR, et al. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16(9):531\u201343.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2299_CR110","doi-asserted-by":"publisher","first-page":"1103617","DOI":"10.3389\/fimmu.2023.1103617","volume":"14","author":"M Zhang","year":"2023","unstructured":"Zhang M, et al. Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer. Front Immunol. 2023;14:1103617.","journal-title":"Front Immunol"},{"issue":"2","key":"2299_CR111","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S2468-1253(21)00294-6","volume":"7","author":"S Danese","year":"2022","unstructured":"Danese S, et al. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. Lancet Gastroenterol Hepatol. 2022;7(2):118\u201327.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"2299_CR112","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/08830185.2023.2249525","volume":"43","author":"S Duan","year":"2024","unstructured":"Duan S, et al. Circulating and intestinal regulatory T cells in inflammatory bowel disease: A systemic review and meta-analysis. Int Rev Immunol. 2024;43(2):83\u201394.","journal-title":"Int Rev Immunol"},{"issue":"7","key":"2299_CR113","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41590-024-01860-7","volume":"25","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans. Nat Immunol. 2024;25(7):1231\u201344.","journal-title":"Nat Immunol"},{"issue":"4","key":"2299_CR114","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41419-019-1540-2","volume":"10","author":"B Zeng","year":"2019","unstructured":"Zeng B, et al. ILC3 function as a double-edged sword in inflammatory bowel diseases. Cell Death Dis. 2019;10(4):315.","journal-title":"Cell Death Dis"},{"issue":"12","key":"2299_CR115","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1016\/j.immuni.2022.11.002","volume":"55","author":"A Frede","year":"2022","unstructured":"Frede A, et al. B cell expansion hinders the stroma-epithelium regenerative cross talk during mucosal healing. Immunity. 2022;55(12):2336-2351.e12.","journal-title":"Immunity"},{"issue":"1","key":"2299_CR116","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.1038\/s41467-021-27112-y","volume":"12","author":"Y Yang","year":"2021","unstructured":"Yang Y, et al. Dysbiosis of human gut microbiome in young-onset colorectal cancer. Nat Commun. 2021;12(1):6757.","journal-title":"Nat Commun"},{"key":"2299_CR117","doi-asserted-by":"publisher","first-page":"8727","DOI":"10.1038\/ncomms9727","volume":"6","author":"G Nakatsu","year":"2015","unstructured":"Nakatsu G, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun. 2015;6:8727.","journal-title":"Nat Commun"},{"issue":"4","key":"2299_CR118","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cmet.2023.03.003","volume":"35","author":"H Chen","year":"2023","unstructured":"Chen H, et al. Urea cycle activation triggered by host-microbiota maladaptation driving colorectal tumorigenesis. Cell Metab. 2023;35(4):651-666.e7.","journal-title":"Cell Metab"},{"key":"2299_CR119","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.canlet.2021.11.027","volume":"526","author":"H Hou","year":"2022","unstructured":"Hou H, et al. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation? Cancer Lett. 2022;526:225\u201335.","journal-title":"Cancer Lett"},{"issue":"3","key":"2299_CR120","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","volume":"30","author":"J Cai","year":"2022","unstructured":"Cai J, Sun L, Gonzalez FJ. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe. 2022;30(3):289\u2013300.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"2299_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2024.05.004","volume":"18","author":"HA Morrison","year":"2024","unstructured":"Morrison HA, et al. NF-\u03baB Inducing Kinase Attenuates Colorectal Cancer by Regulating Noncanonical NF-\u03baB Mediated Colonic Epithelial Cell Regeneration. Cell Mol Gastroenterol Hepatol. 2024;18(3): 101356.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"2299_CR122","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/gutjnl-2012-304241","volume":"63","author":"JL Pope","year":"2014","unstructured":"Pope JL, et al. Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Gut. 2014;63(4):622\u201334.","journal-title":"Gut"},{"issue":"10","key":"2299_CR123","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","volume":"21","author":"M Schmitt","year":"2021","unstructured":"Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21(10):653\u201367.","journal-title":"Nat Rev Immunol"},{"issue":"35","key":"2299_CR124","doi-asserted-by":"publisher","first-page":"14007","DOI":"10.1073\/pnas.1211509109","volume":"109","author":"H Shaked","year":"2012","unstructured":"Shaked H, et al. Chronic epithelial NF-\u03baB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation. Proc Natl Acad Sci U S A. 2012;109(35):14007\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2299_CR125","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","volume":"15","author":"S Grivennikov","year":"2009","unstructured":"Grivennikov S, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 2009;15(2):103\u201313.","journal-title":"Cancer Cell"},{"issue":"3","key":"2299_CR126","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccell.2019.08.003","volume":"36","author":"R Jackstadt","year":"2019","unstructured":"Jackstadt R, et al. Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis. Cancer Cell. 2019;36(3):319-336.e7.","journal-title":"Cancer Cell"},{"issue":"1","key":"2299_CR127","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1038\/s41467-024-45616-1","volume":"15","author":"J Hao","year":"2024","unstructured":"Hao J, et al. Dysregulation of Wnt\/\u03b2-catenin signaling contributes to intestinal inflammation through regulation of group 3 innate lymphoid cells. Nat Commun. 2024;15(1):2820.","journal-title":"Nat Commun"},{"issue":"7121","key":"2299_CR128","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860\u20137.","journal-title":"Nature"},{"issue":"2","key":"2299_CR129","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98\u2013107.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2299_CR130","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","volume":"20","author":"H Tilg","year":"2020","unstructured":"Tilg H, et al. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20(1):40\u201354.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2299_CR131","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","volume":"19","author":"Y Fan","year":"2021","unstructured":"Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55\u201371.","journal-title":"Nat Rev Microbiol"},{"key":"2299_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154712","volume":"117","author":"G Yang","year":"2021","unstructured":"Yang G, et al. Role of the gut microbiota in type 2 diabetes and related diseases. Metabolism. 2021;117: 154712.","journal-title":"Metabolism"},{"issue":"5","key":"2299_CR133","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly CJ, et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe. 2015;17(5):662\u201371.","journal-title":"Cell Host Microbe"},{"key":"2299_CR134","doi-asserted-by":"publisher","first-page":"1067647","DOI":"10.3389\/fnut.2022.1067647","volume":"9","author":"A Mayorga-Ramos","year":"2022","unstructured":"Mayorga-Ramos A, et al. Protective role of butyrate in obesity and diabetes: New insights. Front Nutr. 2022;9:1067647.","journal-title":"Front Nutr"},{"issue":"4","key":"2299_CR135","doi-asserted-by":"publisher","first-page":"747","DOI":"10.4014\/jmb.2312.12031","volume":"34","author":"YR Chae","year":"2024","unstructured":"Chae YR, et al. Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome. J Microbiol Biotechnol. 2024;34(4):747\u201356.","journal-title":"J Microbiol Biotechnol"},{"key":"2299_CR136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.883410","volume":"13","author":"Q Ding","year":"2022","unstructured":"Ding Q, et al. Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes. Front Immunol. 2022;13: 883410.","journal-title":"Front Immunol"},{"issue":"5","key":"2299_CR137","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/S0016-5085(03)00171-9","volume":"124","author":"P Gionchetti","year":"2003","unstructured":"Gionchetti P, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124(5):1202\u20139.","journal-title":"Gastroenterology"},{"issue":"2","key":"2299_CR138","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1053\/gast.2000.9370","volume":"119","author":"P Gionchetti","year":"2000","unstructured":"Gionchetti P, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119(2):305\u20139.","journal-title":"Gastroenterology"},{"issue":"11","key":"2299_CR139","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cgh.2009.07.016","volume":"7","author":"A Sood","year":"2009","unstructured":"Sood A, et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol. 2009;7(11):1202\u20139 1209.e1.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"11","key":"2299_CR140","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/apt.17387","volume":"57","author":"S Ikegami","year":"2023","unstructured":"Ikegami S, et al. Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study. Aliment Pharmacol Ther. 2023;57(11):1249\u201357.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"2299_CR141","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-2036.1995.tb00386.x","volume":"9","author":"P Vernia","year":"1995","unstructured":"Vernia P, et al. Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther. 1995;9(3):309\u201313.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2299_CR142","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2036.2010.04492.x","volume":"33","author":"Z Liu","year":"2011","unstructured":"Liu Z, et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study. Aliment Pharmacol Ther. 2011;33(1):50\u201363.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"2299_CR143","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.7150\/thno.92350","volume":"14","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Bifidobacterium breve-derived indole-3-lactic acid ameliorates colitis-associated tumorigenesis by directing the differentiation of immature colonic macrophages. Theranostics. 2024;14(7):2719\u201335.","journal-title":"Theranostics"},{"key":"2299_CR144","doi-asserted-by":"crossref","unstructured":"Tian Y, Xu Q, Sun L, Ye Y, Ji G. Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development. J Nutr Biochem. 2018;57:103\u2013109.","DOI":"10.1016\/j.jnutbio.2018.03.007"},{"issue":"1","key":"2299_CR145","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12967-023-04306-0","volume":"21","author":"G Li","year":"2023","unstructured":"Li G, et al. The effects of probiotics supplementation on glycaemic control among adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised clinical trials. J Transl Med. 2023;21(1):442.","journal-title":"J Transl Med"},{"issue":"1","key":"2299_CR146","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clnu.2015.11.011","volume":"36","author":"LB Tonucci","year":"2017","unstructured":"Tonucci LB, et al. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin Nutr. 2017;36(1):85\u201392.","journal-title":"Clin Nutr"},{"issue":"4","key":"2299_CR147","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.clnu.2015.07.009","volume":"35","author":"Z Asemi","year":"2016","unstructured":"Asemi Z, et al. Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trial. Clin Nutr. 2016;35(4):819\u201325.","journal-title":"Clin Nutr"},{"key":"2299_CR148","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.clnu.2024.11.042","volume":"44","author":"C Zhang","year":"2025","unstructured":"Zhang C, et al. Effects of synbiotics surpass probiotics alone in improving type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Clin Nutr. 2025;44:248\u201358.","journal-title":"Clin Nutr"},{"key":"2299_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2024.112565","volume":"128","author":"AR Jang","year":"2024","unstructured":"Jang AR, et al. Lactobacillus plantarum NCHBL-004 modulates high-fat diet-induced weight gain and enhances GLP-1 production for blood glucose regulation. Nutrition. 2024;128: 112565.","journal-title":"Nutrition"},{"issue":"5","key":"2299_CR150","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/dom.14967","volume":"25","author":"JP Frias","year":"2023","unstructured":"Frias JP, et al. A microbiome-targeting fibre-enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes: A double-blind, randomized, placebo-controlled trial. Diabetes Obes Metab. 2023;25(5):1203\u201312.","journal-title":"Diabetes Obes Metab"},{"key":"2299_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.107041","volume":"199","author":"J Zheng","year":"2024","unstructured":"Zheng J, et al. Effects of short-chain fatty acids on blood glucose and lipid levels in mouse models of diabetes mellitus: A systematic review and network meta-analysis. Pharmacol Res. 2024;199: 107041.","journal-title":"Pharmacol Res"},{"key":"2299_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102759","volume":"55","author":"G Calderon","year":"2020","unstructured":"Calderon G, et al. Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes. EBioMedicine. 2020;55: 102759.","journal-title":"EBioMedicine"},{"issue":"2","key":"2299_CR153","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2018.20046","volume":"321","author":"SP Costello","year":"2019","unstructured":"Costello SP, et al. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial. JAMA. 2019;321(2):156\u201364.","journal-title":"JAMA"},{"issue":"1","key":"2299_CR154","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","volume":"149","author":"P Moayyedi","year":"2015","unstructured":"Moayyedi P, et al. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015;149(1):102-109.e6.","journal-title":"Gastroenterology"},{"key":"2299_CR155","doi-asserted-by":"publisher","first-page":"1126808","DOI":"10.3389\/fmicb.2023.1126808","volume":"14","author":"H Yu","year":"2023","unstructured":"Yu H, et al. Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses. Front Microbiol. 2023;14:1126808.","journal-title":"Front Microbiol"},{"key":"2299_CR156","doi-asserted-by":"publisher","first-page":"1089991","DOI":"10.3389\/fcimb.2022.1089991","volume":"12","author":"Z Wu","year":"2022","unstructured":"Wu Z, et al. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study. Front Cell Infect Microbiol. 2022;12:1089991.","journal-title":"Front Cell Infect Microbiol"},{"key":"2299_CR157","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.820367","volume":"12","author":"D Ding","year":"2022","unstructured":"Ding D, et al. Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients. Front Cell Infect Microbiol. 2022;12: 820367.","journal-title":"Front Cell Infect Microbiol"},{"key":"2299_CR158","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fcimb.2019.00455","volume":"9","author":"H Wang","year":"2019","unstructured":"Wang H, et al. Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets. Front Cell Infect Microbiol. 2019;9:455.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2299_CR159","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1158\/1940-6207.CAPR-19-0258","volume":"13","author":"L Xu","year":"2020","unstructured":"Xu L, et al. A Phase I Trial of Berberine in Chinese with Ulcerative Colitis. Cancer Prev Res (Phila). 2020;13(1):117\u201326.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"2299_CR160","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.apsb.2019.08.006","volume":"10","author":"H Li","year":"2020","unstructured":"Li H, et al. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions. Acta Pharm Sin B. 2020;10(3):447\u201361.","journal-title":"Acta Pharm Sin B"},{"key":"2299_CR161","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jcis.2024.05.162","volume":"671","author":"C Deng","year":"2024","unstructured":"Deng C, et al. Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy. J Colloid Interface Sci. 2024;671:354\u201373.","journal-title":"J Colloid Interface Sci"},{"key":"2299_CR162","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.phrs.2016.02.010","volume":"110","author":"YH Li","year":"2016","unstructured":"Li YH, et al. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL\/6 mice by suppressing Th17 responses. Pharmacol Res. 2016;110:227\u201339.","journal-title":"Pharmacol Res"},{"key":"2299_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117292","volume":"179","author":"M Wang","year":"2024","unstructured":"Wang M, et al. Integration of microbiome, metabolomics and transcriptome for in-depth understanding of berberine attenuates AOM\/DSS-induced colitis-associated colorectal cancer. Biomed Pharmacother. 2024;179: 117292.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"2299_CR164","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.7150\/ijbs.81824","volume":"19","author":"H Chen","year":"2023","unstructured":"Chen H, et al. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine. Int J Biol Sci. 2023;19(7):2097\u2013113.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2299_CR165","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","volume":"12","author":"SA Harrison","year":"2021","unstructured":"Harrison SA, et al. A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes. Nat Commun. 2021;12(1):5503.","journal-title":"Nat Commun"},{"issue":"1","key":"2299_CR166","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1038\/s41467-021-25952-2","volume":"12","author":"MM Zhao","year":"2021","unstructured":"Zhao MM, et al. Berberine is an insulin secretagogue targeting the KCNH6 potassium channel. Nat Commun. 2021;12(1):5616.","journal-title":"Nat Commun"},{"issue":"5","key":"2299_CR167","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","volume":"57","author":"J Yin","year":"2008","unstructured":"Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712\u20137.","journal-title":"Metabolism"},{"issue":"2","key":"2299_CR168","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","volume":"59","author":"H Zhang","year":"2010","unstructured":"Zhang H, et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 2010;59(2):285\u201392.","journal-title":"Metabolism"},{"issue":"8","key":"2299_CR169","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3748\/wjg.v27.i8.708","volume":"27","author":"JD Zhao","year":"2021","unstructured":"Zhao JD, et al. Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats. World J Gastroenterol. 2021;27(8):708\u201324.","journal-title":"World J Gastroenterol"},{"key":"2299_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.854885","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H, et al. The mechanism of berberine alleviating metabolic disorder based on gut microbiome. Front Cell Infect Microbiol. 2022;12: 854885.","journal-title":"Front Cell Infect Microbiol"},{"key":"2299_CR171","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3389\/fphar.2018.00571","volume":"9","author":"H Cui","year":"2018","unstructured":"Cui H, et al. Berberine Regulates Treg\/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon. Front Pharmacol. 2018;9:571.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2299_CR172","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12885-022-09635-9","volume":"22","author":"H Chen","year":"2022","unstructured":"Chen H, et al. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota. BMC Cancer. 2022;22(1):566.","journal-title":"BMC Cancer"},{"key":"2299_CR173","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154227","volume":"103","author":"Q Sun","year":"2022","unstructured":"Sun Q, et al. Berberine suppresses colorectal cancer by regulation of Hedgehog signaling pathway activity and gut microbiota. Phytomedicine. 2022;103: 154227.","journal-title":"Phytomedicine"},{"issue":"5","key":"2299_CR174","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/ptr.6588","volume":"34","author":"CN Li","year":"2020","unstructured":"Li CN, et al. Berberine combined with stachyose induces better glycometabolism than berberine alone through modulating gut microbiota and fecal metabolomics in diabetic mice. Phytother Res. 2020;34(5):1166\u201374.","journal-title":"Phytother Res"},{"key":"2299_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115430","volume":"167","author":"X Sun","year":"2023","unstructured":"Sun X, et al. Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism. Biomed Pharmacother. 2023;167: 115430.","journal-title":"Biomed Pharmacother"},{"key":"2299_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154217","volume":"102","author":"S Yan","year":"2022","unstructured":"Yan S, et al. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora. Phytomedicine. 2022;102: 154217.","journal-title":"Phytomedicine"},{"issue":"9","key":"2299_CR177","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.chom.2024.07.028","volume":"32","author":"P Guo","year":"2024","unstructured":"Guo P, et al. Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis. Cell Host Microbe. 2024;32(9):1502-1518.e9.","journal-title":"Cell Host Microbe"},{"issue":"6","key":"2299_CR178","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","volume":"35","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, et al. Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity. Cell Metab. 2023;35(6):943-960.e9.","journal-title":"Cell Metab"},{"issue":"4","key":"2299_CR179","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1007\/s12602-021-09744-0","volume":"13","author":"AC Archer","year":"2021","unstructured":"Archer AC, Muthukumar SP, Halami PM. Lactobacillus fermentum MCC2759 and MCC2760 Alleviate Inflammation and Intestinal Function in High-Fat Diet-Fed and Streptozotocin-Induced Diabetic Rats. Probiotics Antimicrob Proteins. 2021;13(4):1068\u201380.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"2299_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.609134","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota. Front Endocrinol (Lausanne). 2021;12: 609134.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2299_CR181","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.7150\/ijbs.65476","volume":"18","author":"Y Dong","year":"2022","unstructured":"Dong Y, et al. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt\/\u03b2-catenin pathway. Int J Biol Sci. 2022;18(4):1381\u201397.","journal-title":"Int J Biol Sci"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02299-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02299-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02299-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T07:02:34Z","timestamp":1750230154000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02299-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":181,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2299"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02299-5","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}